Effect of an inhibitor of nitric oxide production on Cu-Zn/SOD and its cofactors in diabetic rats

Biological Trace Element Research

Volumn 115, Issue 1, 2007, Pages 59-65

  Kocatürk, Pelin Aribal ^a   Kavas, Güzin Özelçi ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Copper; Cu Zn SOD; Diabetes; L NAME; Zinc

Indexed keywords

COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; STREPTOZOCIN; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL LEVEL; CONTROLLED STUDY; COPPER BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ERYTHROCYTE; MALE; NONHUMAN; PROTEIN DETERMINATION; RAT; SPECTROPHOTOMETRY; STREPTOZOCIN DIABETES; TISSUE INJURY; TREATMENT OUTCOME; ZINC BLOOD LEVEL;

ANIMALS; COENZYMES; COPPER; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; SUPEROXIDE DISMUTASE; ZINC;

RATTUS;

EID: 34147217097     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:115:1:59     Document Type: Article

References (25)

1. K. Prasad, S. V. Mantha, A. D. Muir, and N. D. Westcott, Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism, Mol. Cell Biochem. 206, 141-150 (2000).
2. P. Rösen, P. P. Nawroth, G. King, W. Möller, et al., The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society, Diabetes Metab. Res. Rev. 17, 189-212 (2001).
3. H. Tsubouchi, T. Inoguchi, T. Sonta, et al., Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement, Free Radical Biol. Med. 39(4), 444-452 (2005).
4. P. V. Limaye, N. Raghuram, and S. Sivakami, Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induced diabetic rats, Mol. Cell. Biochem. 243, 147-152 (2003).
5. R. B. Steven, D. E. R. Sutherland, J. D. Ansite, et al., Insulin down-regulates the inducible nitric oxide synthase pathway: nitric oxide as cause and effect of diabetes, J. Immunol. 159, 5329-5335 (1997).
6. D. Bonnefont-Rousselot, J. P. Bastard, M. C. Jaudon, and J. Delattre, Consequence of the diabetic status on the oxidant/antioxidant balance, Diabetes Metab. 26, 163-176 (2000).
7. G. M. Pieper, Review of alterations in endothelial nitric oxide production in diabetes, Hypertension 31, 1047-1060 (1998).
8. T. Nishikawa, D. Edelstein, X. L. Du, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature 404, 787-790 (2000).
9. X. L. Du, D. Edelstein, L. Rosseti, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamone pathway and induces plasminogen activator inhibitor-1 expression by increasing SP1 glycosylation, Proc. Natl. Acad. Sci. USA 97, 12,222-12,226 (2000).
10. E. Gonzalez, J. Rosello-Catafau, A. Jawerbaum, et al., Pancreatic nitric oxide and oxygen free radicals in the early stages of streptozotocin-induced diabetes mellitus in the rat, Braz. J. Med. Biol. Res. 33(11), 1335-1342 (2000).
11. W. J. Schnedi, S. Ferber, J. H. Johnson, and C. B. Newgard, STZ transport and cytotoxicity, Diabetes 1326-1333 (1994).
12. H. Chen, E. C. Carison, L. Pellet, J. T. Moritz, and P. N. Epstein, Overexpression of metallothionein in pancreatic β-cells reduces streptozotocin-induced DNA damage and diabetes, Diabetes 50, 2040-2046 (2001).
13. C. C. Winterbourn, R. E. Hawkins, M. Brian, and R. W. Carrel, Red cell superoxide dismutase activity, J. Lab. Clin. Med. 85, 337-350 (1975).
14. Perkin-Elmer, Analysis of serum determination of copper and zinc(BC-5), in Analytical Method for Atomic Absorption Spectrophotometry, Perkin-Elmer Corp., Norwalk, CT (1973).
15. S. P. Wolff, Diabetes mellitus and free radicals, Br. Med. Bull. 49, 642-652 (1993).
16. S. P. Wolff, Z. Y. Jiag, and J. V. Hundt, Protein glycation and oxidative stress in diabetes mellitus and ageing, Free Radical Biol. Med. 10, 339-352 (1991).
17. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice, Diabetes 50, 2114-2125 (2001).
18. G. M. Pieper and G. J. Gross, Oxygen free radicals abolish endothelium dependent relaxation in diabetic art aorta, Am. J. Physiol. 255, H825-H833 (1998).
19. T. Adachi, H. Ohta, K. Hirano, K. Hayashi, and S. L. Marklund, The site of nonenzymic glycation of human extracellular superoxide dismutase in vitro, Free Radical Biol. Med. 279, 263-267 (1991).
20. J. Brandao-Nero, C. A. B. Siva, N. B. Figueiredo, T. Shuhama, M. B. S. Holanda, and J. M. M. Diniz, Zinc kinetics in insulin-dependent diabetes mellitus patients, Biol. Metals 13, 141-145 (2000).
21. K. R. Etzel and R. J. Cousins, Hyperglycemic action of zinc in rats, J. Nutr. 113, 1657-1663 (1983).
22. J. Y. Uriu-Adams, R. B. Rucker, J. F. Commisso, and C. L. Keen, Diabetes and dietary copper alter 67Cu metabolism and oxidant defense in the rat, J. Nutr. Biochem. 16(5), 312-320 (2005).
23. M. I. Chen and M. L. Failla, Metallothionein metabolism in the liver and kidney of the streptozotocin-diabetic rat, Comp. Biochem. Physiol. B 90, 439-445 (1988).
24. J. Y. Uriu-Adams and C. L. Keen, Copper, oxidative stress, and human health, Mol. Aspects Med. 26(4-5), 268-298 (2005).
25. N. Shukla, C. S. Thompson, G. D. Angelini, D. P. Mikhailidis, and J. Y. Jeremy, Low micromolar concentrations of copper augment the impairment of endothelium-dependent relaxation of aortae from diabetic rabbits, Metabolism 53(10), 1315-1321 (2004).